FDA announces major reforms to streamline biosimilar approvals, potentially saving Americans billions on prescription drug costs by removing extra clinical trial requirements.

Boston-based Vertex reported revenue of $3.08 billion, an 11 percent gain from one year ago. That was ahead of analysts’ ...

The consumer products giant reached a $40 billion deal to buy Kenvue, the maker of Tylenol, despite a barrage of unproven ...

Sarepta said on Monday that its late-stage study testing two gene-targeted therapies for Duchenne muscular dystrophy did not ...

The government is tying itself in knots to cast murder as self-defense and avoid legal limits on the president's use of the ...

Developers of biosimilars, medicines that are near-identical copies of biologic drugs, will no longer be required to conduct clinical trials to prove effectiveness.

Parents and clinicians are urged to review usage of certain health products for young children after federal authorities ...

There are nearly 16,500 pharmacies, hospitals, and businesses, in addition to many police departments, that offer safe ...

Howard University says the gift comes at an “opportune time” as the government shutdown has delayed annual federal ...

Type 1 diabetes is an autoimmune disease (typically arising in younger people) that occurs when your immune system attacks ...

The Food and Drug Administration issued an alert affecting more than 580,800 bottles of Prazosin Hydrochloride capsules ...

The US Food and Drug Administration (FDA) has issued a recall of approximately 580,000 bottles of a commonly prescribed blood ...